Effect of Ilex Paraguariensis Harvest Time and Consumption Method of Processed Yerba Mate on the Lipid Profile
NCT ID: NCT06896175
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
198 participants
INTERVENTIONAL
2026-02-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Beta-Glucan on Cholesterol Lowering
NCT01408719
Effect of Consumption of Chaya on Lipid Concentration and Antioxidant Status of Patients With Dyslipidemia
NCT04110392
Supplementation With Flaxseed Oil in the State of Rio de Janeiro
NCT01604681
Effect of Palm Olein Intake on Lipid Profile and Fat Deposition
NCT02897674
Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors
NCT00927199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YM mate
Yerba consumption of mate only
Yerba mate consumption (Ilex paraguayensis) A
Yerba mate of the begining of the harvest time
Yerba mate comsuption (ilex paraguayencis) B
Yerba mate of the final time of the harvest
YM terere
Yerba mate terere consumption only
Yerba mate consumption (Ilex paraguayensis) A
Yerba mate of the begining of the harvest time
Yerba mate comsuption (ilex paraguayencis) B
Yerba mate of the final time of the harvest
YM mate and terere
Yerba mate consuptiom as mate and terere
Yerba mate consumption (Ilex paraguayensis) A
Yerba mate of the begining of the harvest time
Yerba mate comsuption (ilex paraguayencis) B
Yerba mate of the final time of the harvest
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yerba mate consumption (Ilex paraguayensis) A
Yerba mate of the begining of the harvest time
Yerba mate comsuption (ilex paraguayencis) B
Yerba mate of the final time of the harvest
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Consumers of mate or tereré and mate/terere who agree to consume the yerba mate samples provided by the research team, which will be masked from laboratory analysis.
3. Two weeks of abstinence from consuming prepared yerba mate, either as mate or tereré, prior to randomization for the trial.
4. Consume exclusively prepared yerba mate in the prescribed manner (quantity of yerba, frequency of consumption, and sips), either in its mate or tereré form independently, and for those who consume both forms daily.
5. Do not change the yerba mate consumer's usual diet or regular physical activity during the trial period.
6. Agree to know the laboratory results of the lipid profile only at the end of the trial (180 days after the start).
Exclusion Criteria
2. Consuming any other type of yerba mate not provided by the principal investigator.
3. Individuals requiring vitamins as a nutritional supplement.
4. Individuals taking thermogenic supplements.
5. Individuals consuming cooked mate.
6. Addiction to medicinal plants or herbs, both mate and tereré.
7. Individuals with a personal history of coronary artery disease.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Nacional de Itaugua, MSPyBS, Paraguay)
UNKNOWN
Instituto Nacional de Salud, Paraguay
OTHER
Universidad de La Frontera
OTHER
McMaster University
OTHER
Universidad del Cauca
OTHER
Universidad Nacional de Caaguazu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guiomar Viveros
Role: STUDY_CHAIR
Universidad Nacional de Caaguazu, Facultad de Ciencias de la Salud
Gloria Gonzalez
Role: STUDY_DIRECTOR
Universidad Nacional de Caaguazu, Facultad de Ciencias de la Salud
Angel Rolon
Role: PRINCIPAL_INVESTIGATOR
Universidad Nacional de Caaguazu, Facultad de Ciencias de la Salud
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PINV01-1074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.